BridgeBio Pharma (BBIO) EBT Margin Growth (1y) (2020 - 2026)
BridgeBio Pharma (BBIO) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
4,249.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,249.00 |
| Dec 31, 2025 |
439,997.00 |
| Sep 30, 2025 |
585,773.00 |
| Jun 30, 2025 |
332,020.00 |
| Mar 31, 2025 |
-9,138.00 |
| Dec 31, 2024 |
648,266.00 |
| Sep 30, 2024 |
-175,398.00 |
| Jun 30, 2024 |
639,844.00 |
| Mar 31, 2024 |
777,471.00 |
| Dec 31, 2023 |
-324,798.00 |
| Sep 30, 2023 |
3.91 Mn |
| Jun 30, 2023 |
-974,776.00 |
| Mar 31, 2023 |
365,399.00 |
| Dec 31, 2022 |
-595,530.00 |
| Sep 30, 2022 |
-3.65 Mn |
| Jun 30, 2022 |
109,460.00 |
| Mar 31, 2022 |
2.68 Mn |
| Dec 31, 2021 |
11.13 Mn |
| Sep 30, 2021 |
-523,833.00 |
| Sep 30, 2020 |
-139,987.00 |
